Category: drug costs

KFF Health News’ ‘What the Health?’: On Abortion Rights, Ohio Is the New Kansas

Nearly a year to the day after Kansas voters surprised the nation by defeating an anti-abortion ballot question, Ohio voters defeated a similar, if cagier, effort to limit access in that state. This week, they rejected an effort to raise the threshold for approval of future ballot measures from a simple majority, which would have made it harder to protect abortion access with yet another ballot question come November. Meanwhile, the number of Americans without health insurance has dropped to an all-time low, though few noticed. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Roubein of The Washington Post, and Emmarie Huetteman of KFF Health News join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews Kate McEvoy, executive director of the National Association of Medicaid Directors, about how the “Medicaid unwinding” is going, as millions have their eligibility for coverage rechecked.

Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers

Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.

Survey: Americans Want Weight Loss Drugs Despite High Cost

A new poll reveals enthusiasm for a pricey new generation of weight loss drugs, but interest drops if users potentially have to deal with weekly injections, lack of insurance coverage, or a need to continue the medications indefinitely to avoid regaining weight.

The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers

The annual cost of lecanemab treatment quadruples if the expense of brain scans to monitor for bleeds and other associated care is factored in. The full financial toll likely puts it beyond reach for low-income seniors at risk of Alzheimer’s, experts say.

New Weight Loss Drugs Carry High Price Tags and Lots of Questions for Seniors

Although nearly 40% of Americans 60 and older are obese, Medicare doesn’t cover weight loss medications. Meanwhile, studies haven’t thoroughly examined new drugs’ impact on older adults.

KFF Health News’ ‘What the Health?’: The Long Road to Reining in Short-Term Plans 

It took more than two years, but the Biden administration has finally kept a promise made by then-candidate Joe Biden to roll back the Trump administration’s expansion of short-term, limited-duration health plans. The plans have been controversial because, while they offer lower premiums than more comprehensive health plans, they offer far fewer benefits and are […]

Wait, What’s a PBM?

Pharmacy benefit managers, or PBMs, are companies that negotiate the prices of prescription drugs. Hear about their role in raising drug prices and the ongoing efforts to regulate this complex industry.

What You Need to Know About the Drug Price Fight in Those TV Ads

At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients.

Patients Squeezed in Fight Over Who Gets to Bill for Pricey Infusion Drugs

To drive down costs, insurers are bypassing hospital system pharmacies and delivering high-priced infusion drugs, including some used in chemotherapy, via third-party pharmacies. Smarting from losing out on billing for those drugs, hospitals and clinics are trying to convince states to limit this practice, known as “white bagging.”

Slow Your Disenroll

More than a million Americans have lost Medicaid coverage since pandemic protections ended. The Biden administration is asking states to slow disenrollment, but that does not mean states must listen. Meanwhile, a Supreme Court decision gives Medicaid beneficiaries the right to sue over their care, and a new deal preserves coverage of preventive services nationwide as a Texas court case continues. Rachel Cohrs of Stat, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KFF Health News’ Mary Agnes Carey to discuss these issues and more. Also this week, KFF Health News’ Julie Rovner interviews Dan Mendelson, CEO of Morgan Health, a new unit of JPMorgan Chase, about employers’ role in insurance coverage.